Performance of a Validated Risk Score to Predict HIV-1 Acquisition Among African Women Participating in a Trial of the Dapivirine Vaginal Ring

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):e8-e10. doi: 10.1097/QAI.0000000000001556.

Jennifer E Balkus^{1

2

3}, Elizabeth R Brown^{1

4}, Thesla Palanee-Phillips⁵, Flavia Matovu Kiweewa⁶, Nyaradzo Mgodi⁷, Logashvari Naidoo⁸, Yamikani Mbilizi⁹, Nitesha Jeenarain⁸, Zakir Gaffoor⁸, Samantha Siva⁸, Gonasangrie Nair¹⁰, Arendevi Pather⁸, Jared M Baeten^{2

3

11}

¹ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
² Departments of Global Health.
³ Epidemiology.
⁴ Biostatistics, University of Washington, Seattle, WA.
⁵ Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
⁶ Makerere University, Johns Hopkins University Research Collaboration, Kampala, Uganda.
⁷ University of Zimbabwe, Harare, Zimbabwe.
⁸ South African Medical Research Council, Durban, South Africa.
⁹ Medical College of Malawi-Johns Hopkins University Research Collaboration, Blantyre, Malawi.
¹⁰ Emavundleni Research Centre, Cape Town, South Africa.
¹¹ Department of Medicine, University of Washington, Seattle, WA.

No abstract available

Publication types